You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
德視佳(01846.HK):冀年內在港開旗艦診所 正與巴黎業界洽商
阿思達克 02-14 08:04
德視佳(01846.HK)主席及行政總裁約根森表示,希望今年在香港開立旗艦矯視診所,認為現時是以可負擔預算物色優質地點的好時機,正在與不同眼科醫生日後為集團在港提供服務。他指,集團擅長的高度近視的治療(ICL晶狀體植入術)和老花眼的治療,在香港並不普遍,因此認為這個市場有巨大機遇,日後在港會主力發展這兩項業務。 公司在2019年10月在聯交所主板上市。約根森認為,中國市場是公司在亞洲內主要增長動力所在,因此透過上市集資尋求增長機會,而中國市場增長強勁,因此選擇在香港上市。他指出,在歐洲人們因疫情長期逗留家中,因此有金錢預算和時間接受矯視,令集團業務在德國快速增長,不過相信中國在明年進一步重啟經濟活動後,長遠來說中國市場增速會超越歐洲。 公司上月公布收購倫敦視力矯正服務公司London Vision Clinic全部股權,經調整後最高代價約3,432.8萬英鎊,將以現金以及透過發行新股支付。約根森預計,London Vision Clinic息稅前利潤(EBIT)每年可以增長35%,其業務涉獵PRESBYOND視覺融合激光術,集團沒有在歐洲和中國內提供這項技術的治療,因此收購可以讓集團接觸到全新的客群、產生新收入來源。 他稱,集團服務深受德國內華人歡迎,倫敦有10萬華人居住,希望倫敦診所同樣地能吸納這群客人,另外巴黎有逾50萬華人居住,讓集團關注這個市場,集團正在與巴黎內的業界洽商,日後若進入該市場將採取併購方式,不會直接自行開立業務。 約根森認為,集團在併購時,亦希望吸納優秀的醫生和新技術,並希望收購標的成為集團的夥伴。首席財務官布朗(Markus Braun)指,日後的併購將視乎賣方意願和個別收購標的,決定以發新股或其他方式等支付代價。 集團計劃在今年早期在成都和哥本哈根開新診所,在今年下半年在德國威斯巴登及於今年第四季在基爾開新診所。布朗稱,開每一間新診所,預計平均需要200萬歐元資金,一般情況下需要1至1.5年時間達致收支平衡,視乎地點而定,而且集團會以經營現金流和上市時所籌款項支付開新診所費用,毋需額外集資以開立新診所。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account